Advisor Group’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $38K | Buy |
231
+11
| +5% | +$1.81K | ﹤0.01% | 3579 |
|
2019
Q3 | $32K | Sell |
220
-8
| -4% | -$1.16K | ﹤0.01% | 3681 |
|
2019
Q2 | $48K | Buy |
228
+6
| +3% | +$1.26K | ﹤0.01% | 3386 |
|
2019
Q1 | $46K | Buy |
222
+7
| +3% | +$1.45K | ﹤0.01% | 3447 |
|
2018
Q4 | $37K | Sell |
215
-8
| -4% | -$1.38K | ﹤0.01% | 3394 |
|
2018
Q3 | $51K | Buy |
223
+18
| +9% | +$4.12K | ﹤0.01% | 3268 |
|
2018
Q2 | $32K | Sell |
205
-35
| -15% | -$5.46K | ﹤0.01% | 3410 |
|
2018
Q1 | $43K | Buy |
240
+83
| +53% | +$14.9K | ﹤0.01% | 3171 |
|
2017
Q4 | $33K | Buy |
157
+25
| +19% | +$5.26K | ﹤0.01% | 3367 |
|
2017
Q3 | $28K | Sell |
132
-6
| -4% | -$1.27K | ﹤0.01% | 3357 |
|
2017
Q2 | $26K | Hold |
138
| – | – | ﹤0.01% | 3316 |
|
2017
Q1 | $35K | Buy |
138
+38
| +38% | +$9.64K | ﹤0.01% | 2974 |
|
2016
Q4 | $25K | Hold |
100
| – | – | ﹤0.01% | 3080 |
|
2016
Q3 | $20K | Buy |
100
+33
| +49% | +$6.6K | ﹤0.01% | 3136 |
|
2016
Q2 | $5K | Buy |
+67
| New | +$5K | ﹤0.01% | 3762 |
|